Cargando…
Neoantigen Specific T Cells Derived From T Cell-Derived Induced Pluripotent Stem Cells for the Treatment of Hepatocellular Carcinoma: Potential and Challenges
Immunotherapy has become an indispensable part of the comprehensive treatment of hepatocellular carcinoma (HCC). Immunotherapy has proven effective in patients with early HCC, advanced HCC, or HCC recurrence after liver transplantation. Clinically, the most commonly used immunotherapy is immune chec...
Autores principales: | Lu, Fei, Ma, Xiao-Jing-Nan, Jin, Wei-Lin, Luo, Yang, Li, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155510/ https://www.ncbi.nlm.nih.gov/pubmed/34054880 http://dx.doi.org/10.3389/fimmu.2021.690565 |
Ejemplares similares
-
Neoantigens as potential vaccines in hepatocellular carcinoma
por: Repáraz, David, et al.
Publicado: (2022) -
Mutation-Derived Neoantigens for Cancer Immunotherapy
por: Castle, John C., et al.
Publicado: (2019) -
The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives
por: Liu, Xin, et al.
Publicado: (2017) -
Advances in Adoptive Cell Therapy Using Induced Pluripotent Stem Cell-Derived T Cells
por: Netsrithong, Ratchapong, et al.
Publicado: (2021) -
Induced Pluripotent Stem Cell-Derived Monocytes/Macrophages in Autoinflammatory Diseases
por: Tanaka, Takayuki, et al.
Publicado: (2022)